Navigation Links
Hanger Reports Second Quarter 2013 Results
Date:7/31/2013

%Income before taxes

8.2%11.1%7.3%8.9%Provision for income taxes

3.1%4.2%2.7%3.4%Net income 

5.1%6.9%4.6%5.5%Adjusted income from operations

13.5%14.3%11.9%12.3%Adjusted net income

6.8%7.0%5.6%5.6% 

 Hanger, Inc.( in thousands, except for statistical data)(Unaudited)Three Months EndedSix Months EndedJune 30,June 30,Cash Flow Data:2013201220132012Cash flow provided by operations 

$
24,526$
25,709$
26,719$
27,001Capital expenditures

$
2,647$
,654$
8,045$
5,970Increase/(decrease) in cash and cash equivalents

$
(9,267)$
9,365$
(13,445)$
(1,283)Balance Sheet Data:June 30, 2013December 31, 2012Cash and cash equivalents$
5,766$
9,211Days Sales Outstanding (DSO's) *5958Working Capital $
266,540$
251,465Total Debt$
504,474$
520,646Shareholders' Equity$
533,048$
503,094*Excludes acquired accounts receivable balancesThree Months EndedSix Months EndedJune 30,June 30,2013201220132012Revenue Mix:Patient Care

84.4%82.6%83.6%81.9%Products and Services

15.6%17.4%16.4%18.1%Patient Care Payor Mix:Commercial and other

59.0%58.6%59.4%58.7%Medicare

29.1%29.5%28.8%29.4%Medicaid

5.7%5.9%5.6%5.9%VA

6.2%6.0%6.2%6.0%Management relies on the non-GAAP items as the primary measures to review and assess operating performance and management teams. The Company believes it is useful to investors to provide disclosures of its operating results on the same basis as that used by management.  Management and investors also review the non-GAAP items to evaluate the Company's overall performance and to compare its current operating results with corresponding periods and with other companies in the health care industry. You should not consider the non-GAAP items in isolation or as a substitute for net income, operating cash flows or other cash flow statement data determined in acco
'/>"/>

SOURCE Hanger, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Hanger clinicians honored with 2012 Tribeca Disruptive Innovation Award
2. Hanger Orthopedic Group, Inc. announces name change to Hanger, Inc.
3. Hanger, Inc. Announces Second Quarter 2012 Earnings Release Conference Call
4. Hanger, Inc. Reports Earnings of $0.50 Per Diluted Share for the Second Quarter 2012
5. Hanger, Inc. Announces 2012 Year To Date Acquisitions Totaling $35.6 Million Of Annual Net Revenue
6. Hanger Reports Earnings of $0.50 Per Diluted Share for the Third Quarter 2012
7. Hanger, Inc. Has Record Year In O&P Acquisitions:
8. Hanger Reports $0.62 Diluted EPS for the Fourth Quarter 2012
9. Hanger Files Form 10-K for Year Ended December 31, 2012
10. Hanger, Inc. Announces First Quarter 2013 Earnings Release And Conference Call
11. Hanger Reports First Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... and PITTSBURGH , Aug. 28, ... today announced that its shareholders have approved Mylan,s ... PRGO ; TASE) and the related issuance of ... extraordinary general meeting of shareholders held today. The ... at the extraordinary general meeting. In addition, the ...
(Date:8/28/2015)... , August 28, 2015 ... to reach USD 49.12 billion by 2020, growing at ... to a new report by Grand View Research, Inc. ... CAGR of 49.7% from 2014 to 2020. ... aging population along with rising incidences of chronic diseases ...
(Date:8/27/2015)... 27, 2015 ieCrowd™ today announced the ... development of the company,s supplemental oxygen delivery device, ... being developed by ieCrowd,s subsidiary Smart Oxygen Solutions ... demand for oxygen based on level of activity.  ... for the Smart Oxygen device would require a ...
Breaking Medicine Technology:Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4
... CINCINNATI, April 1, 2011 CarePoint Partners, one of ... in the United States, launched a food drive today ... the less fortunate in the communities where it operates. ... conducted throughout the month of April. CarePoint Partners is ...
... Inc. (OTCBB: PLCSF), a company focused on innovative medical ... REMEDIAL II investigator-sponsored clinical trial of its RenalGuard System™ ... a.m. CT on Monday, April 4, 2011, at the ... & Expo in New Orleans, Louisiana. Additionally, PLC will ...
Cached Medicine Technology:CarePoint Partners Kicks Off Food Drive to Help Fight Hunger in Twenty-One Local Communities 2REMEDIAL II Results on PLC System's RenalGuard® to be Presented at ACC 2011's Late Breaking Clinical Trial Session 2REMEDIAL II Results on PLC System's RenalGuard® to be Presented at ACC 2011's Late Breaking Clinical Trial Session 3
(Date:8/30/2015)... ... August 30, 2015 , ... Certified Nutrition Businessman Reid Eckert agrees ... and InHealth media is a global sales and communications firm that offers U.S. brands ... continue our business relationship with Mr. Reid Eckert, as his interpretation of the nutritional ...
(Date:8/30/2015)... ... August 30, 2015 , ... SonaCare Medical, ... the treatment of prostate cancer, has announced the roll-out of its newest technology ... center in Puerto Vallarta, Mexico. , The Sonablate® technology currently in use at ...
(Date:8/29/2015)... Church, VA (PRWEB) , ... August 30, 2015 ... ... **FDAnews Webinar**, Sept. 15, 2015 — 1:30 p.m. – 3:00 p.m. EDT, ... much more than a simple digital handwritten signature. , Clinical trial ...
(Date:8/29/2015)... ... 29, 2015 , ... It can be uncomfortable to wear ... and sweat. "In order to prevent these problems, I conceived of my design," ... MEN'S UNDERGARMENT provides optimal support for a male’s crotch. It improves comfort for ...
(Date:8/29/2015)... ... August 29, 2015 , ... Brands like Toppik , Eau Thermale ... costs. , “Before, a threshold of $49.00 was required to qualify for free standard ... for free standard shipping for customers regardless of the item’s selling price.” , With ...
Breaking Medicine News(10 mins):Health News:Nutrition Guru Continues Relationship With Renowned Health and Wellness Company 2Health News:Image Fusion Technology Combines MRI and Ultrasound Images to Treat Prostate Cancer 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 3Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 4Health News:Modified Men’s Underwear Promote More Comfort and Hygiene - Designed by InventHelp Client (LGI-1968) 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2
... ... Enterprise Staffing and Scheduling Earned the Highest Score Based on Direct Product Evaluations and ... ... September 9, 2009 -- Today at the Nursing Management Congress2009, RES-Q® Healthcare Systems announced ...
... , WALTHAM, Mass., Sept. 9 ... research and advisory firms focusing on pharmaceutical and healthcare issues, ... messages among the ten surveyed osteoporosis brands likely as a ... commonly recalled that Sally Field promoted the brand or that ...
... , ATLANTA, Sept 9 The government,s ... improving health and appearance are still available. , , ... program offers a top-of-the-line skin rejuvenation and repair procedure - ... David R. Fern, FACS. Dr. Fern and the Vein & Skin ...
... , PRINCETON, N.J., Sept. 9 NephroGenex, Inc., ... announced the completion of patient enrollment in its Phase 2b clinical ... candidate Pyridorin(TM) (pyridoxamine dihydrochloride ) in type 2 diabetic patients ... have been randomized. , , The ...
... , , , ... -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX ) ... Caldolor((R)), an intravenous formulation of ibuprofen, designed primarily for use in ... available in the United States for the treatment of pain and ...
... ... partners with MSO packaging and Sun Chemical to provide comprehensive security solution which ... provide custom technology solutions which help prevent counterfeiting and diversion of products, within ... ...
Cached Medicine News:Health News:RES-Q Labor Resource Management Ranked as the Top Staff Scheduling System Solution in KLAS 2009 Special Report 2Health News:Both Patients and Physicians Most Frequently Recall Roche's Boniva Messages and Link Them to the Sally Field Osteoporosis Campaign 2Health News:Both Patients and Physicians Most Frequently Recall Roche's Boniva Messages and Link Them to the Sally Field Osteoporosis Campaign 3Health News:'Cash For Crow's Feet' Program Offers Effective - and Affordable - Laser Skin Treatments 2Health News:NephroGenex Announces Full Enrollment in New Pyridorin(TM) Clinical Trial - PYR 210 2Health News:Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever 2Health News:Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever 3Health News:Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever 4Health News:Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever 5Health News:Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever 6Health News:Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever 7Health News:Providers of Packaging Design, Security Printing, and Track and Trace Technology Allign to Provide Multi-Layered Brand Protection Solution 2Health News:Providers of Packaging Design, Security Printing, and Track and Trace Technology Allign to Provide Multi-Layered Brand Protection Solution 3Health News:Providers of Packaging Design, Security Printing, and Track and Trace Technology Allign to Provide Multi-Layered Brand Protection Solution 4Health News:Providers of Packaging Design, Security Printing, and Track and Trace Technology Allign to Provide Multi-Layered Brand Protection Solution 5
Mathews hand drill, with knurled shank and rotating head....
Hudson Downs hand drill....
Io is a surgical digital microscope with head mounted display HMD (Callisto)....
... the development of the minimally ... innovative solution that allows microsurgery ... less invasive. The olympus MINI ... surgical microscope, the neuroendoscope upgrade ...
Medicine Products: